company background image
MDKA logo

Medika d.d ZGSE:MDKA Stock Report

Last Price

€7.40k

Market Cap

€214.3m

7D

-2.6%

1Y

58.1%

Updated

25 Mar, 2024

Data

Company Financials

MDKA Stock Overview

Medika d.d., together with its subsidiaries, engages in the wholesale and retail distribution of pharmaceutical products in the Republic of Croatia.

MDKA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends3/6

Medika d.d. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Medika d.d
Historical stock prices
Current Share Price€7,400.00
52 Week High€7,900.00
52 Week Low€4,580.00
Beta0.071
1 Month Change0%
3 Month Changen/a
1 Year Change58.12%
3 Year Change195.08%
5 Year Change264.33%
Change since IPO592.28%

Recent News & Updates

Recent updates

Statutory Profit Doesn't Reflect How Good Medika d.d's (ZGSE:MDKA) Earnings Are

Jul 29
Statutory Profit Doesn't Reflect How Good Medika d.d's (ZGSE:MDKA) Earnings Are

Shareholder Returns

MDKAHR HealthcareHR Market
7D-2.6%-0.7%2.2%
1Y58.1%-3.0%27.1%

Return vs Industry: MDKA exceeded the HR Healthcare industry which returned -3.2% over the past year.

Return vs Market: MDKA exceeded the HR Market which returned 30.3% over the past year.

Price Volatility

Is MDKA's price volatile compared to industry and market?
MDKA volatility
MDKA Average Weekly Movementn/a
Healthcare Industry Average Movement4.7%
Market Average Movement4.1%
10% most volatile stocks in HR Market7.9%
10% least volatile stocks in HR Market2.5%

Stable Share Price: MDKA has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine MDKA's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1922990Jasminko Herceghttps://www.medika.hr

Medika d.d., together with its subsidiaries, engages in the wholesale and retail distribution of pharmaceutical products in the Republic of Croatia. The company primarily sells, stores, and distributes human and veterinary drugs, and equipment and dental supplies, as well as dietetic, cosmetic, hygienic, medicinal, and other products. It serves pharmacies, healthcare institutions, hospitals, health centers, outpatient facilities, doctor’s offices, wholesalers, and specialized stores; and dental practices, veterinary clinics, and medical centers, as well as herbal pharmacies, companies, optics, and others.

Medika d.d. Fundamentals Summary

How do Medika d.d's earnings and revenue compare to its market cap?
MDKA fundamental statistics
Market cap€214.26m
Earnings (TTM)€20.08m
Revenue (TTM)€750.49m

10.7x

P/E Ratio

0.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MDKA income statement (TTM)
Revenue€750.49m
Cost of Revenue€690.85m
Gross Profit€59.64m
Other Expenses€39.56m
Earnings€20.08m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)693.51
Gross Margin7.95%
Net Profit Margin2.68%
Debt/Equity Ratio20.4%

How did MDKA perform over the long term?

See historical performance and comparison

Dividends

2.9%

Current Dividend Yield

35%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.